According to a new report by UnivDatos, the "Latent TB Testing market" is expected to reach USD Billion in 2032 by growing at a CAGR of 7.8%.

Key Highlights of the Report:

Market Overview: The issues related to the recent sectors in the testing market for latent TB are described in the report together with the key drivers, challenges, and the regional picture for the development of the industry.

Segment Insights: It examines principal types of tests such as Tuberculin Skin Tests (TSTs) and Interferon Gamma Release Assays (IGRAs) and their market use.

Regional Analysis: Comprehensive results of market analysis by geographic regions with emphasis on the promising areas such as North America, Asia Pacific, and Europe are provided.

Competitive Landscape: Top market players are included in the evaluation of their approaches to market, product launches, and partnerships defining competition.

Future Opportunities: Opportunities that help the industry grow include Point of care testing new entrants, Artificial intelligence integration, and Public-private collaboration.

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/latent-tb-testing-market?popup=report-enquiry

Latent TB Testing determines individuals with asymptomatic Mycobacterium tuberculosis infection who are likely to develop overt TB. Screening tests include the Tuberculin Skin Test (TST) and Interferon Gamma Release Assays (IGRAs), which identify a body’s reaction to the bacteria. These tests are important in the prevention of TB epidemics among multiple risk groups such as the immunocompromised as well as the healthcare givers. This is mainly due to the increasing rates of tuberculosis across the world increasing the need to detect latent TB to prevent active TB. Also, improvements in diagnostic tools like IGRAs increase the effectiveness and utilization in high-risk groups. In addition, TB control campaigns supported by the government and compulsory screening norms also contribute to the growth of the market.

On November 25 2023, Revvity, a global company that leverages innovation in Diagnostics and Life Sciences announced the country launch of its T-SPOT.TB test for latent TB screening, at MICROCON in Lucknow.

In March 2022, PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021.

Segments that transform the industry

Based on application, the market is segmented into household contacts (HHC) of tuberculosis (TB) patients, people living with HIV (PLHIV), and others. People living with HIV are expected to grow with a significant CAGR during the forecast period (2024-2032). The PLHIV segment is one of the primary consumers in the latent TB testing market because such patients have a higher risk of developing active TB and, therefore, require regular and accurate tests. The recent expansion of tuberculosis diagnostics in HIV care programs worldwide has boosted the need for gender-precise and accurate tests such as IGRAs. Companies adopt by developing partnerships with HIV clinics and NGOs to deliver specific test solutions and by providing affordable easy-to-scale testing solutions to this risky group.

According to the report, the impact of Latent TB Testing has been identified to be high for the Asia-Pacific area. Some of how this impact has been felt include:

As per the World Health Organization, In 2022, eight countries accounted for more than two-thirds of global TB cases: India (27%), Indonesia (10%), China (7.1%), the Philippines (7.0%), Pakistan (5.7%), Nigeria (4.5%), Bangladesh (3.6%) and the Democratic Republic of the Congo (3.0%).

Asia-Pacific is expected to grow with a significant CAGR during the forecast period (2024-2032). This is due to a high tuberculosis incidence rate, improved understanding of the disease, and national efforts to eliminate the disease. Adding to this, large-scale screening is being carried out in countries such as India and China with the help of international organizations. Examples include offering low-cost diagnostic solutions, forming alliances with government organizations, and increasing market coverage to areas that have limited access to the products. A shift from conventional TSTs to advanced IGRAs within the urban regions also supports the growth of the market. 

Click here to view the Report Description & TOC : https://univdatos.com/reports/latent-tb-testing-market

Key Offerings of the Report

Market Size, Trends, & Forecast by Revenue | 2024−2032.

Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities

Market Segmentation – A detailed analysis By Test Type, By Application, By End User, By Region/Country

Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Contact Us:

UnivDatos

Contact Number - +1 978 733 0253

Email - contact@univdatos.com 

Website - www.univdatos.com

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/